A newly developed open-source model from the IPECAD project is transforming how early Alzheimer’s treatments are evaluated. With a focus on transparency and cross-validation, the model provides critical insights for decision-makers like NICE and CMS, especially when considering new treatments. However, this model also faces some challenges. While it ensures reproducibility, it overlooks key real-world complexities, such as patient heterogeneity and the full cost of diagnostic infrastructure. Are these limitations undermining its potential accuracy? To further explore the implications of this model, join members from the Brain Watch Coalition on how it could shape the future of Alzheimer’s treatment and promote better brain health. We invite you to be part of this critical conversation and submit comments here.
Brain Watch Coalition
Non-profit Organizations
A global health partnership assuring accurate, affordable, and equitable access to brain health care and treatments
About us
The Campaign to Prevent Alzheimer’s Disease (PAD 20|20) is unlike other non-profits and academic institutions. The organization seeks solutions for the most formidable challenges to curing and caring for cognitive impairment, dementia, and other brain disorders. Using a vast global network, the organization excels at mobilizing and engaging a network of key international opinion leaders from government, academia, industry, and advocacy groups to transform strategic plans into real-world solutions. More remarkably, since 2009, PAD 20|20’s leading-edge workgroups, teams, and projects have helped spur public and private research investment for dementia and brain aging to over $10 billion in North America, Europe, and Asia. The Brain Watch Coalition integrates experts under the auspices of PAD20|20, a Maryland-based non-profit, tax-exempt organization under Section 501(c)(3) of the Internal Revenue Code. BWC's composition, organization, and operation will be international and virtual. As a collaborative not-for-profit independent international project, BWC commits to building a better world through brain health.
- Website
-
www.brainwatchcoalition.org
External link for Brain Watch Coalition
- Industry
- Non-profit Organizations
- Company size
- 2-10 employees
- Type
- Nonprofit
- Founded
- 2022
- Specialties
- Brain Health, Public Health, Non-profit, Alzheimer's disease, Dementia, Cognitive Impairment, Advocacy, Serious gaming, Healthcare systems, Public Policy, Global Health, Population Health, Health Equity, Rural Health, Digital Health, Artificial Intelligence, Digital Therapeutics, Individualized Medicine, Complexity Science, and Implementation Science
Updates
-
So, what exactly is Wall Street's interest in health care? Is it to pursue the IHI's Quadruple aims? Gretchen Morgenson, an investigative journalist for NBC News, a former stockbroker, and a Pulitzer Prize winner, has written a remarkable accounting of a behavioral health clinic that serves children and a care service industry under stress. Who else is looking at this situation? Is this limited to just North America? Please share your thoughts. https://lnkd.in/gkRFRukx
-
If you don't know Klaus, please send him a note of introduction and congratulations. He is an important ally in trying to maintain an individual's autonomy and independence as they live with many chronic brain disorders.
C-Path is thrilled to announce that Dr. Klaus Romero has been named its new Chief Executive Officer. Please join us in congratulating Klaus on his leadership, dedication and CEO appointment at C-Path. Dr. Romero, a seasoned clinician scientist, has been vital in positioning C-Path as an essential partner in accelerating drug development worldwide, significantly shaping scientific and regulatory pathways to expedite the delivery of therapies for people in urgent need. With an impressive tenure of over 16 years at C-Path, he has held key positions within the organization including Chief Science Officer and Executive Director of both Clinical Pharmacology and the Quantitative Medicine Program. His pivotal role in establishing and leading the Quantitative Medicine Program underscores his significant contributions to C-Path’s critical initiatives in drug development over the years. Full details: https://lnkd.in/gBYYWttB #CPath #newCEO #globalhealth #drugdevelopment #datasharing #collaboration #regulatoryscience #quantitativemedicine #clinicalpharmacology
-
-
Constantly learning new strategies from Brittany Cassin, MBA, about responsible development of AI/ML-powered digital brain health solutions.
My Every Day is Committed to Brain Health | AI-technology Commercialization Leader
I am excited to speak at the #ValueBasedCare Summit, Dec. 5-6 in DC. Can't wait to engage with Zenobia Brown MD, MPH of Northwell Health, Tom Lawry, Top #AI Voice to Watch and former Microsoft Executive, and the one and only Mendel Erlenwein, Podcast Host and Author as we tackle the topic: Unleashing the Power of #AI in Value-Based Care. Learn more below👇 DigiCARE Realized EnableHealth LLC Mark Stevens, FHIMSS Matthew Foran Malaz Boustani Zina BenMiled Ishtar Govia Phil Gutis Ara Khachaturian The Healthcare Innovation Company (thINc) Andre Ong #thINcVBC #VBC
-
-
Excellent interview--DigiCARE Realized is poised to drive sustainable and responsible adoption of 21st century digital health technologies that lead to more affordable, accurate and accessible interventions that promote brain health.
In this week's Medicarians Live interview we learn how the prison system motivated Brittany Cassin, MBA to start her company DigiCARE Realized to help modernize care for complex brain diseases. 🧠 Wanna see 👀 more? Brittnay talks: -using AI responsibly -commercializing digital medicine -sharing your lived experience to help get equitable healthcare Watch ▶ our full interview here https://lnkd.in/eGCR_kwk #MedicariansVegas #Medicarians2024 #seniorhealth #seniorwealth #agetech #AI #healthequity #digitalhealth